Delivery Order SPE2DB24D9803-SPE2DB25FJSNV
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $19,690.47 firm fixed-price delivery order is for the supply of TRIUMEQ 600-50-300 MG TABLET UU 30S, a specialized pharmaceutical product. The contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program. This IDC...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,017.57 for emtricitabine and related pharmaceutical products by the Defense Logistics Agency's Medical Supply Chain on September 12, 2025, with completion scheduled for September 22, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a task order under DMS Pharmaceutical Group's existing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,035.14 firm fixed-price delivery order contract covers the supply of emtricitabine and tenofovir disoproxil fumarate, a combination HIV medication, with a period of performance through September 5, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $1,937.50 under an indefinite delivery contract with the Defense Logistics Agency to supply emtricitabine and tenofovir alafenamide tablets. The delivery order was awarded on June 10, 2022 with a completion date of June 20, 2022. No set-aside designation was used for this award. DMS Pharmaceutical Group Inc. will provide the pharmaceutical items to Defense Logistics Agency Troop Support Medical facilities...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,017.57 by the Defense Logistics Agency's Medical Supply Chain on August 1, 2025. The delivery order, which covers Emtricitabine and related pharmaceutical products, is set to be completed by August 11, 2025, with performance taking place at the contractor's Park Ridge facility. This award was issued without a set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,017.57 by the Defense Logistics Agency's Medical Supply Chain division on August 13, 2025. The award covers the supply of Emtricitabine and related pharmaceutical products, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was issued without a set-aside designation, allowing the contractor to compete...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at one thousand nine hundred thirty-seven dollars and fifty cents ($1,937.50) by the Defense Logistics Agency Troop Support Medical. This order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceutical items and medical products to support military treatment facilities worldwide. Under this particular order, DMS Pharmaceutical Group will provide...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $3,052.71 for Emtricitabine and related pharmaceutical products by the Defense Logistics Agency (DLA) Medical Supply Chain. This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of August 25, 2025, represents a single transaction under DMS Pharmaceutical Group's existing Indefinite Delivery...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at one thousand five hundred eighty-five dollars and sixty-four cents ($1,585.64) by the Defense Logistics Agency. This order is placed against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceutical items and medical products to support military treatment facilities worldwide. Under this particular order, DMS Pharmaceutical Group will provide sixty tablets of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order valued at $1,017.57 from the Defense Logistics Agency's Medical Supply Chain on July 25, 2025. The contract covers the supply of Emtricitabine and related pharmaceutical products to support federal healthcare requirements. The delivery order was issued without a set-aside designation and is scheduled for ultimate completion by August 4,...
- SPE2DB24D9803Indefinite Delivery Contract
- SPE2DB24D9803-SPE2DB25FJSNVDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,586.22 to DMS Pharmaceutical Group Inc. for 30 units of Triumeq 600-50-300 mg tablets. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with a completion date of September 12, 2025. This delivery order was issued without a set-aside designation, allowing the company to compete on a full and open basis despite its small business status. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at approximately $500 million and valid through November 2026. The parent IDC enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription medications, biologics, and medical consumables to support Department of Defense healthcare facilities nationwide. Triumeq, an HIV treatment medication, represents the type of specialized pharmaceutical product the contractor routinely supplies to military health systems through this strategic partnership.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 9/11/25 |